Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/128409
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRowan, J.A.-
dc.contributor.authorRush, E.C.-
dc.contributor.authorPlank, L.D.-
dc.contributor.authorLu, J.-
dc.contributor.authorObolonkin, V.-
dc.contributor.authorCoat, S.-
dc.contributor.authorHague, W.M.-
dc.date.issued2018-
dc.identifier.citationObstetrical and Gynecological Survey, 2018; 73(10):565-567-
dc.identifier.issn0029-7828-
dc.identifier.issn1533-9866-
dc.identifier.urihttp://hdl.handle.net/2440/128409-
dc.descriptionEditorial Comment-
dc.description.abstractThis study was a follow-up study to the prospective randomized controlled trial comparing metformin versus insulin. In particular, it compared the body composition and metabolic outcomes at 7 to 9 years of children born to women with gestational diabetes mellitus (GDM) randomized to metformin (±insulin) or insulin treatment during pregnancy.-
dc.description.statementofresponsibilityJanet A. Rowan, Elaine C. Rush, Lindsay D. Plank, Jun Lu, Victor Obolonkin, Suzette Coat, and William M. Hague-
dc.language.isoen-
dc.publisherLippincott, Williams & Wilkins-
dc.rightsCopyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1097/01.ogx.0000547170.99000.49-
dc.titleMetformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age-
dc.typeJournal article-
dc.identifier.doi10.1097/01.ogx.0000547170.99000.49-
pubs.publication-statusPublished-
dc.identifier.orcidCoat, S. [0000-0002-3836-2854]-
dc.identifier.orcidHague, W.M. [0000-0002-5355-2955]-
Appears in Collections:Aurora harvest 8
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.